Burden of illness of HER2+in metastatic breast cancer (MBC) patients: A systematic literature review (SLR)

被引：0
|
作者：
Vondeling, G. [1 ]
Harding, T. [2 ]
Seddik, A. [3 ]
Bakker, K. [4 ]
Velikanova, R. [4 ]
机构：
[1] Univ Groningen, Groningen, Netherlands
[2] AstraZeneca, Hlth Econ & Payer Evidence, Cambridge, England
[3] Dauchi Sankyo, Global Hlth Econ & Real World Evidence, Munich, Germany
[4] Asc Acad BV, Hlth Econ & Market Access, Groningen, Netherlands
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
287P
引用
收藏
页码：S490 / S490
页数：1
相关论文
共 50 条
  • [31] Trastuzumab deruxtecan, its efficacy in patients with metastatic HER2-positive breast cancer: a systematic review
    Fernhandho, V.
    Jhoputri, C. Fricilia
    Julian, L.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1337 - S1337
  • [32] THE BENEFIT OF HER-2 TARGETED THERAPIES ON OVERALL SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER - A SYSTEMATIC REVIEW
    Alves, C.
    Mendes, D.
    Andrade, S.
    Marques, Batel F.
    VALUE IN HEALTH, 2014, 17 (07) : A620 - A620
  • [33] The economic burden of HER2-targeted therapy among metastatic breast cancer patients
    Forero-Torres, Andres
    Anupindi, Vamshi Ruthwik
    Yeaw, Jason
    DeKoven, Mitch
    Feliciano, Joseph
    Richhariya, Akshara
    CANCER RESEARCH, 2020, 80 (04)
  • [34] Landscape of HER2-low metastatic breast cancer (MBC): Results from the AGMT-MBC-Registry
    Gampenrieder, Simon Peter
    Rinnerthaler, Gabriel
    Petzer, Andreas
    Tinchon, Christoph
    Fuchs, David
    Balic, Marija
    Heibl, Sonja
    Rumpold, Holger
    Egle, Daniel
    Zabernigg, August Felix
    Singer, Christian Fridolin
    Andel, Johannes
    Hubalek, Michael
    Knauer, Michael
    Greil, Richard
    CANCER RESEARCH, 2020, 80 (04)
  • [35] The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review
    Diogo Mendes
    Carlos Alves
    Noémia Afonso
    Fátima Cardoso
    José Luís Passos-Coelho
    Luís Costa
    Sofia Andrade
    Francisco Batel-Marques
    Breast Cancer Research, 17
  • [36] The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer - a systematic review
    Mendes, Diogo
    Alves, Carlos
    Afonso, Noemia
    Cardoso, Fatima
    Passos-Coelho, Jose Luis
    Costa, Luis
    Andrade, Sofia
    Batel-Marques, Francisco
    BREAST CANCER RESEARCH, 2015, 17
  • [37] Metronomic Chemotherapy for Metastatic Breast Cancer - a Systematic Review of the Literature
    Banys-Paluchowski, M.
    Schuetz, F.
    Ruckhaeberle, E.
    Krawczyk, N.
    Fehm, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (05) : 525 - 534
  • [38] Social determinants of health (SDOH) and survival among patients with metastatic prostate cancer (mPC): A systematic literature review (SLR).
    Freedland, Stephen J.
    Niyazov, Alexander
    Nazari, Jonathan
    Worthington, Evelyn
    Lansing, Austin
    Rosta, Emily
    Samjoo, Imtiaz
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [39] Long-term response to regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A systematic literature review (SLR)
    Peeters, M.
    Pan, X.
    Koufopoulou, M.
    Arregui, M.
    Wissinger, E.
    Ostojic, H.
    Pisa, F.
    Kim, R. D.
    ANNALS OF ONCOLOGY, 2024, 35 : S30 - S31
  • [40] Systematic literature review of clinical trials of endocrine therapies for premenopausal women with metastatic HR+HER2-breast cancer
    Patterson-Lomba, Oscar
    Dalal, Anand A.
    Ayyagari, Rajeev
    Liu, Olivia
    Dervishi, Eni
    Platt, Emma
    Chandiwana, David
    O'Shaughnessy, Joyce A.
    BREAST JOURNAL, 2019, 25 (05): : 880 - 888
12345